CUBT (Curative Biotechnology) Total Operating Expense: $3.80 Mil (TTM As of Mar. 2023)


What is Curative Biotechnology Total Operating Expense?

Curative Biotechnology CUBT +19.71% Total Operating Expense is $3.80 Mil as of Mar. 2023.

Curative Biotechnology's Total Operating Expense for the three months ended in Mar. 2023 was $0.66 Mil. Curative Biotechnology's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2023 was $3.80 Mil.

Curative Biotechnology Total Operating Expense Related Terms

Curative Biotechnology Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Curative Biotechnology's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biotechnology Total Operating Expense Chart

Curative Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Operating Expense
Get a 7-Day Free Trial 0.01 0.01 4.60 5.00 4.44

Curative Biotechnology Quarterly Data
Dec16 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.29 0.96 1.08 1.10 0.66

Curative Biotechnology Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $3.80 Mil mean?
Curative Biotechnology (CUBT) has a Total Operating Expense of $3.80 Mil as of Mar. 2023. Total operating expense is the primary recurring expense associated with central operations. View historical data on Curative Biotechnology and its competitors.
Is Curative Biotechnology's Total Operating Expense too high?
Curative Biotechnology's current Total Operating Expense is $3.80 Mil.
How does Curative Biotechnology's Total Operating Expense compare to ORGS and SNSE?
Curative Biotechnology's Total Operating Expense of $3.80 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Curative Biotechnology and its competitors. Curative Biotechnology's current Total Operating Expense is $3.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curative Biotechnology stock overvalued right now?
Curative Biotechnology (CUBT) has a current Total Operating Expense of $3.80 Mil. The current Total Operating Expense is $3.80 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Curative Biotechnology (CUBT), the current Total Operating Expense is $3.80 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curative Biotechnology Business Description

Address 3801 PGA Boulevard, Suite 600, Palm Beach Gardens, FL, USA, 33410
Curative Biotechnology Inc is a development-stage biomedical company focusing on novel treatments for rare diseases. The Company is identifying, acquiring, and developing disease-modifying therapeutic drug candidates with a concentration on rare disease indications. Curative Biotech currently has ongoing programs in three different therapeutic areas: degenerative eye disease, infectious disease, and neuro-oncology. The Company is now concentrating its energy and resources on its degenerative eye disease platform.